Literature DB >> 10998318

Predominate HIV1-specific IgG activity in various mucosal compartments of HIV1-infected individuals.

F X Lü1.   

Abstract

Evaluating mucosal humoral immunity is important for understanding local immunity induced by HIV infection or vaccination and designing prophylactic strategies. To characterize the mucosal humoral immunity following HIV infection, the levels of immunoglobulins (Igs), antibodies (Abs), and HIV1-specific Ab activity were evaluated in cervicovaginal secretions (CVS), saliva, breast milk, and sera of HIV-infected individuals. HIV1-specific IgG activity was significantly higher than that of IgA in CVS, saliva, and breast milk. The highest HIV1-specific IgG activity was found in breast milk. The data suggest that anti-HIV1 Abs in CVS were most likely serum derived. However, HIV1-specific Abs in saliva and breast milk were mainly locally produced. The prevalence of HIV1-specific Abs in seropositive subjects was 97% for IgG and 95% for IgA in CVS, 100% for IgG and 80% for IgA in saliva, and 59% for IgG and 94% for IgA in breast milk. These data provide evidence for both a better understanding of the nature of humoral mucosal responses after HIV1 infection and the development of strategies to induce desirable functional mucosal immunity for preventing HIV transmission. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10998318     DOI: 10.1006/clim.2000.4910

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  14 in total

1.  Scarcity or absence of humoral immune responses in the plasma and cervicovaginal lavage fluids of heavily HIV-1-exposed but persistently seronegative women.

Authors:  Jiri Mestecky; Peter F Wright; Lucia Lopalco; Herman F Staats; Pamela A Kozlowski; Zina Moldoveanu; Rashada C Alexander; Rose Kulhavy; Claudia Pastori; Leonard Maboko; Gabriele Riedner; Yuwei Zhu; Terri Wrinn; Michael Hoelscher
Journal:  AIDS Res Hum Retroviruses       Date:  2010-11-22       Impact factor: 2.205

2.  Robust vaccine-elicited cellular immune responses in breast milk following systemic simian immunodeficiency virus DNA prime and live virus vector boost vaccination of lactating rhesus monkeys.

Authors:  Andrew B Wilks; Elizabeth C Christian; Michael S Seaman; Piya Sircar; Angela Carville; Carmen E Gomez; Mariano Esteban; Giuseppe Pantaleo; Dan H Barouch; Norman L Letvin; Sallie R Permar
Journal:  J Immunol       Date:  2010-11-01       Impact factor: 5.422

3.  Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection.

Authors:  Zili Li; Senthilkumar Palaniyandi; Rongyu Zeng; Wenbin Tuo; Derry C Roopenian; Xiaoping Zhu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-28       Impact factor: 11.205

4.  Limited contribution of mucosal IgA to Simian immunodeficiency virus (SIV)-specific neutralizing antibody response and virus envelope evolution in breast milk of SIV-infected, lactating rhesus monkeys.

Authors:  Sallie R Permar; Andrew B Wilks; Elizabeth P Ehlinger; Helen H Kang; Tatenda Mahlokozera; Rory T Coffey; Angela Carville; Norman L Letvin; Michael S Seaman
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

5.  Association of HIV-1 Envelope-Specific Breast Milk IgA Responses with Reduced Risk of Postnatal Mother-to-Child Transmission of HIV-1.

Authors:  Justin Pollara; Erin McGuire; Genevieve G Fouda; Wes Rountree; Josh Eudailey; R Glenn Overman; Kelly E Seaton; Aaron Deal; R Whitney Edwards; Gerald Tegha; Deborah Kamwendo; Jacob Kumwenda; Julie A E Nelson; Hua-Xin Liao; Christie Brinkley; Thomas N Denny; Christina Ochsenbauer; Sascha Ellington; Caroline C King; Denise J Jamieson; Charles van der Horst; Athena P Kourtis; Georgia D Tomaras; Guido Ferrari; Sallie R Permar
Journal:  J Virol       Date:  2015-07-22       Impact factor: 5.103

6.  Targeting the vaginal mucosa with human papillomavirus pseudovirion vaccines delivering simian immunodeficiency virus DNA.

Authors:  Shari N Gordon; Rhonda C Kines; Galyna Kutsyna; Zhong-Min Ma; Anna Hryniewicz; Jeffery N Roberts; Claudio Fenizia; Rachmat Hidajat; Egidio Brocca-Cofano; Nicolas Cuburu; Christopher B Buck; Marcelino L Bernardo; Marjorie Robert-Guroff; Christopher J Miller; Barney S Graham; Douglas R Lowy; John T Schiller; Genoveffa Franchini
Journal:  J Immunol       Date:  2011-12-14       Impact factor: 5.422

Review 7.  Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection.

Authors:  Zdenek Hel; Elizabeth Stringer; Jiri Mestecky
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

8.  HIV-specific antibodies capable of ADCC are common in breastmilk and are associated with reduced risk of transmission in women with high viral loads.

Authors:  Jennifer Mabuka; Ruth Nduati; Katherine Odem-Davis; Dylan Peterson; Julie Overbaugh
Journal:  PLoS Pathog       Date:  2012-06-14       Impact factor: 6.823

9.  Defense-in-depth by mucosally administered anti-HIV dimeric IgA2 and systemic IgG1 mAbs: complete protection of rhesus monkeys from mucosal SHIV challenge.

Authors:  Anton M Sholukh; Jennifer D Watkins; Hemant K Vyas; Sandeep Gupta; Samir K Lakhashe; Swati Thorat; Mingkui Zhou; Girish Hemashettar; Barbara C Bachler; Donald N Forthal; Francois Villinger; Quentin J Sattentau; Robin A Weiss; Gloria Agatic; Davide Corti; Antonio Lanzavecchia; Jonathan L Heeney; Ruth M Ruprecht
Journal:  Vaccine       Date:  2015-03-11       Impact factor: 3.641

10.  Adaptive HIV-specific B cell-derived humoral immune defenses of the intestinal mucosa in children exposed to HIV via breast-feeding.

Authors:  Sandrine Moussa; Mohammad-Ali Jenabian; Jean Chrysostome Gody; Josiane Léal; Gérard Grésenguet; Alain Le Faou; Laurent Bélec
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.